Drug
Olodaterol clinical trials
Also written BI 1744 CL.
- studies test it
- 57
- open now
- 0
- in phase 3
- 26
- first study started
- 2005
How studies write it
Studies that test it under each name
Name
Brand
Development codes
Studies by the year they started
57 studies that test it; most in 2009 (8)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 4 |
| 2008 | 6 |
| 2009 | 8 |
| 2010 | 6 |
| 2011 | 3 |
| 2012 | 8 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 5 |
| 2020 | 1 |
| 2021 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 12
- Phase 2
- 11
- Phase 3
- 26
- Phase 4
- 7
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 52 · Other 5
Boehringer Ingelheim (52) · University of Dundee (2) · Yonsei University (1) · Erasme University Hospital (1) · Queen's University (1)
Often tested with
Tested in the same studies.
Tiotropium (25) · Fluticasone furoate (1) · Vilanterol (1) · Ciclesonide (1)
Studies
Open first, then newest update. How each study uses olodaterol is read from its arms, and is right about nine times in ten.
Testing it · 57
- Effects of Tiotropium/Olodaterol on Cardio-pulmonary Exercise Capacity in Patients With Hyperinflated Chronic Obstructive Pulmonary Disease [ACHIEVE]CompletedNot applicableYonsei UniversityNCT04994574Written as tiotropium/olodaterol
- Effects of Acute Long-acting Bronchodilation on Oxygenation and Peripheral Ventilation in COPDCompletedPhase 3Erasme University HospitalNCT05927155Written as LABA
- A Study to Test the Combination of Tiotropium and Olodaterol Using the Respimat® Inhaler in People With Chronic Obstructive Pulmonary Disease (COPD) Who Have Different Abilities to InhaleCompletedPhase 4Boehringer IngelheimNCT04223843Written as Tiotropium + olodaterol
- INvestigating COPD Outcomes, Genomics and Neutrophilic Inflammation With Tiotropium and OlodaterolCompletedPhase 4University of DundeeNCT03152149Written as Tiotropium & olodaterol
- The ENERGITO® 2 Study Compares 2 Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD). One Medicine is a Combination of Tiotropium and Olodaterol (Stiolto®) Taken Using the Respimat® Inhaler and the Other Medicine is a Combination of Fluticasone and Salmeterol Taken Using the DiskusCompletedPhase 4Boehringer IngelheimNCT03240575Written as Olodaterol
- Effect of Tiotropium + Olodaterol on Breathlessness in COPD PatientsCompletedPhase 4Boehringer IngelheimNCT02853123Written as Olodaterol
- Cardiovascular Function in COPD PatientsCompletedPhase 4Boehringer IngelheimNCT03055988Written as Olodaterol
- Ultra-long Acting Bronchodilator Therapy in Smoking AsthmaticsCompletedPhase 4University of DundeeNCT02682862Written as olodaterol hydrochloride 2.5mcg, tiotropium bromide 2.5mcg
- Comparing the Efficacy of Tiotropium + Olodaterol Fixed Dose Combination (FDC) Over Tiotropium in Improvement of Lung Hyperinflation, Exercise Capacity and Physical Activity in Japanese COPD PatientsCompletedPhase 3Boehringer IngelheimNCT02629965Written as olodaterol
- Bioavailability of Tiotropium + Olodaterol Fixed-dose Combination (5 μg/ 5 μg) in Chinese COPD PatientsCompletedPhase 1Boehringer IngelheimNCT02969317Written as Olodaterol
- Effects of Dual Bronchodilator Treatment on Cardiopulmonary Interactions in COPDCompletedPhase 4Queen's UniversityNCT03425617Written as Tiotropium + Olodaterol
- Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.CompletedPhase 3Boehringer IngelheimNCT02296138Written as olodaterol
- To Evaluate the Effect of Inhaled Medication Together With Exercise and Activity Training on Exercise Capacity and Daily Activities in Patients With Chronic Lung Disease With Obstruction of AirwaysCompletedPhase 3Boehringer IngelheimNCT02085161Written as tiotropium+olodaterol
- A Study to Determine the Effect of Tiotropium + Olodaterol Fixed Dose Combination on Exercise Endurance Time During Constant Work Rate Cycle Ergometry Test in COPDCompletedPhase 3Boehringer IngelheimNCT01525615Written as tiotropium+olodaterol (low dose)
- Characterization of Lung Function Profile of Inhaled Tiotropium + Olodaterol Fixed Dose Combination Compared to Fluticasone Propionate + Salmeterol Fixed Dose Combination in COPD PatientsCompletedPhase 3Boehringer IngelheimNCT01969721Written as olodaterol
- Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary DiseaseCompletedPhase 3Boehringer IngelheimNCT00932646Written as BI 1744 (Olodaterol) Low Dose
- Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2)CompletedPhase 3Boehringer IngelheimNCT02006732Written as olodaterol
- Pharmacokinetics and Safety of BI 1744 CL Plus Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 1Boehringer IngelheimNCT02231177Written as BI 1744 CL
- Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)CompletedPhase 3Boehringer IngelheimNCT01964352Written as olodaterol
- Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients.CompletedPhase 3Boehringer IngelheimNCT01533935Written as Tiotropium + Olodaterol
See all 57 studies that test olodaterol →
Given in every arm · 4 — olodaterol is usual care beside what is tested
- Comparative Efficacy of Once-daily LAMA/LABA Combinations Versus Tiotropium on Constant-work-rate Cycle Endurance in COPDSuspendedNot applicableMedical University of BialystokNCT07541378Written as Olodaterol
- Bronchodilator Effect of RPL554 Administered in Addition to Tiotropium/Olodaterol in Patients With COPDCompletedPhase 2Verona Pharma plcNCT03673670Written as Tiotropium/olodaterol (Respimat)
- Relative Bioavailability of Olodaterol and FluconazoleCompletedPhase 1Boehringer IngelheimNCT01153724Written as BI 1744
- Relative Bioavailability of of Olodaterol and KetoconazoleCompletedPhase 1Boehringer IngelheimNCT01153711Written as BI 1744
As the comparator · 4 — what is tested is compared with olodaterol
- ANTES B+ Clinical TrialTerminatedPhase 4Fundacio Privada Mon Clinic BarcelonaNCT06282861Written as Striverdi
- Fixed Dose Combination Versus Free Combination of Tiotropium and Olodaterol in COPDCompletedPhase 4Boehringer IngelheimNCT02683109Written as Olodaterol
- Safety, Tolerability and Pharmacokinetics of the Fixed Dose Combination of BI 1744 CL Plus BI 54903 XX Via Respimat® B Versus the Mono Products of BI 1744 CL Via Respimat® A and BI 54903 XX Via Respimat® B in Healthy Male and Female VolunteersCompletedPhase 1Boehringer IngelheimNCT02222428Written as BI 1744 CL
- Safety, Tolerability and Pharmacokinetics of the Fixed Dose Combination of BI 1744 CL Plus BI 54903 XX Via Respimat® B Versus the Free Combination of BI 1744 CL Via Respimat® A and BI 54903 XX Via Respimat® B in Healthy Male and Female VolunteersCompletedPhase 1Boehringer IngelheimNCT02220660Written as BI 1744 CL
Codes
What other systems call olodaterol · ClinicalTrials.gg INT005634
- MeSH (NLM) C549647olodaterolConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) VD2YSN1AFDOLODATEROLConfirmed FDA, NLM, Wikidata
- RxNorm 1546059Confirmed FDA, Wikidata
- Wikidata Q7088466olodaterolConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C170249OlodaterolOne source FDA
- DrugBank DB09080One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C549647 | olodaterol | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | VD2YSN1AFD | OLODATEROL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1546059 | — | Confirmed FDA, Wikidata |
| Wikidata | Q7088466 | olodaterol | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C170249 | Olodaterol | One source FDA |
| DrugBank | DB09080 | — | One source Wikidata |
Also registered as olodaterol hydrochloride (UNII 65R445W3V9 · RxNorm 1546396).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.